Clinical trial

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

NCT02949843

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Laboratory Biomarker Analysis Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Nivolumab Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Pembrolizumab Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Targeted Molecular Therapy Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tyrosine Kinase Inhibitor Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-03-10

PhasePHASE2

Conditions

EGFR Activating Mutationunresolved

Recurrent Non-Small Cell Lung Carcinomaunresolved

Stage IV Non-Small Cell Lung Cancerunresolved

Interventions

ChemotherapyDRUG

ImmunotherapyBIOLOGICAL

Laboratory Biomarker AnalysisOTHER

NivolumabBIOLOGICAL

PembrolizumabBIOLOGICAL

Targeted Molecular TherapyDRUG

Tyrosine Kinase InhibitorDRUG

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02949843 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.